The FDA breakthrough devices program is a voluntary program for certain medical devices and device-led combination products. Through the program, patients have timely access to the latest medical devices, meaning they get better, faster care and treatments for life-threatening or irreversibly debilitating diseases or conditions.
The goal of the program is to accelerate the development, assessment, and review of devices while still adhering to the statutory standards for premarket approval, 510(k) clearance, and De Novo marketing authorization. The breakthrough devices program replaces the Expedited Access Pathway (EAP) and Priority Review programs for medical devices. However, devices granted designation under the Expedited Access Pathway are also considered part of the program.